Covid-19 roundup: Eu­rope pur­chas­es 80M dos­es of Mod­er­na's vac­cine; CO­V­AXX se­cures $2.8B in emerg­ing mar­ket pre-or­ders

With the an­nounce­ment of its vac­cine ef­fi­ca­cy da­ta last week, Mod­er­na is start­ing to line up cus­tomers for its Covid-19 mR­NA jabs.

The Mass­a­chu­setts-based biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER